Biodesix
BDSX
30 hedge funds and large institutions have $31M invested in Biodesix in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.04% less ownership
Funds ownership: 1.11% → 1.07% (-0.04%)
9% less funds holding
Funds holding: 33 → 30 (-3)
16% less capital invested
Capital invested by funds: $36.9M → $31M (-$5.9M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$837K |
| 2 |
BlackRock
New York
|
+$739K |
| 3 |
LCM
Legato Capital Management
San Francisco,
California
|
+$355K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$255K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.13M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$283K |
| 3 |
Millennium Management
New York
|
-$248K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$42K |
| 5 |
E
Ergoteles
New York
|
-$33.7K |
BDSX Hedge Fund Activity: Q1 2023 in Review
30 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2023, worth a combined $31M — down 16% from $36.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BDSX and 4 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 11 added.
The largest buyer was Essex Investment Management, adding an estimated $837K. The largest seller was AIGH Capital Management, cutting an estimated $1.13M.
- 30 institutional investors held Biodesix (BDSX) as of Q1 2023, down from 33 in Q4 2022.
- Funds reported $31M of Biodesix stock for Q1 2023, down 16% quarter-over-quarter.
- 4 funds opened new Biodesix positions in Q1 2023 and 7 closed out, a net change of -3 holders.
- The largest Biodesix buyer in Q1 2023 was Essex Investment Management, an estimated $837K added.
- The largest Biodesix seller in Q1 2023 was AIGH Capital Management, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2023.